The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
- 13 April 1995
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 332 (15), 993-997
- https://doi.org/10.1056/nejm199504133321504
Abstract
The antiphospholipid-antibody syndrome is a thrombophilic disorder in which venous or arterial thrombosis, or both, may occur in patients with antiphospholipid antibodies. The optimal treatment of these patients is unclear. We assessed the efficacy of warfarin, low-dose aspirin, or both in the secondary prevention of thrombosis in patients with the syndrome.Keywords
This publication has 27 references indexed in Scilit:
- Clinical Trials on Antiphospholipid Syndrome: What is Being Done and What is Needed?Lupus, 1994
- Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancerThe Lancet, 1994
- Stroke and Parkinson's disease.Stroke, 1992
- Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III.Stroke, 1990
- Trial of Different Intensities of Anticoagulation in Patients with Prosthetic Heart ValvesNew England Journal of Medicine, 1990
- The “Primary” Antiphospholipid SyndromeMedicine, 1989
- Fixed minidose warfarin: a new approach to prophylaxis against venous thrombosis after major surgery.BMJ, 1987
- SYNDROME OF THE BLACK SWANRheumatology, 1987
- Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1982
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958